tiprankstipranks
Seelos Therapeutics (SEELQ)
OTHER OTC:SEELQ
US Market
SEELQ
Seelos Therapeutics
RESEARCH TOOLSreports
Want to see SEELQ full AI Analyst Report?

Seelos Therapeutics (SEELQ) Income Statement

1,202 Followers

Seelos Therapeutics Income Statement

Last quarter (Q2 2024), Seelos Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Seelos Therapeutics's net income was $1.71M. See Seelos Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 2.20M$ ―$ ―$ ―$ 151.00K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ ―$ ―$ ―$ ―$ ―
EBITDA
$ -37.75M$ -73.47M$ -64.45M$ -18.94M$ -51.23M
Operating Income
$ -40.50M$ -70.92M$ -61.67M$ -18.76M$ -34.99M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -37.88M$ -73.53M$ -66.05M$ -19.10M$ -51.26M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
 ― ― ― ― ―
Weighted Average Shares Outstanding (Diluted)
 ― ― ― ― ―
Currency in USD

Seelos Therapeutics Earnings and Revenue History